Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-013988
Filing Date
2022-05-16
Accepted
2022-05-16 17:37:38
Documents
1
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2711
  Complete submission text file 0001493152-22-013988.txt   3993
Mailing Address C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 1609 NEW YORK NY 10170
Business Address
Denoyer Bernard (Reporting) CIK: 0001397636 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41386 | Film No.: 22931283

Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Issuer) CIK: 0001849296 (see all company filings)

EIN.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)